The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
作者信息
Gudiksen Katherine L, King Jaime S
出版信息
J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.
Abstract
摘要
相似文献
1
The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.
2
Prescription-drug prices.
N Engl J Med. 2004 Sep 30;351(14):1375-7. doi: 10.1056/NEJMp048158.
3
States on the Front Line: Addressing America's Drug Pricing Problem.
J Leg Med. 2019 Apr-Jun;39(2):81-93. doi: 10.1080/01947648.2019.1645544.
4
An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.
5
Value-Based Pricing and State Reform of Prescription Drug Costs.
JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.
6
Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32.
7
Government commitment and regulation of prescription drugs.
Health Aff (Millwood). 2003 May-Jun;22(3):46-8. doi: 10.1377/hlthaff.22.3.46.
8
The Pay-Twice Critique, Government Funding, and Reasonable Pricing Clauses.
J Leg Med. 2019 Apr-Jun;39(2):177-211. doi: 10.1080/01947648.2019.1648942.
9
McKesson settling up. $190 million payment latest in drug-price flap.
Mod Healthc. 2012 Apr 30;42(18):14.
10
Can price and regulatory controls replace free market competition in the drug industry?
Healthspan. 1993 Nov;10(10):30-2.
Zotero 插件